市場調查報告書
商品編碼
1218831
全球化合物管理市場:到2028預測—按類型(產品和服務),樣本類型(生物樣本和化合物),應用(基因合成,生物銀行和藥物發現),最終用戶和地區進行分析Compound Management Market Forecasts to 2028 - Global Analysis By Type (Products and Services), Sample Type (Bio Samples and Chemical Compounds), Application(Gene Synthesis, Bio Banking and Drug Discovery), End User and By Geography |
根據 Stratistics MRC 的數據,全球複合管理市場規模將在 2022 年達到 4.3168 億美元,到 2028 年達到 11.166 億美元,預測期內復合年增長率為 16.8%。預計將增長在
化合物管理,也稱為化合物管理,定義為化學品庫的管理,包括更新過期化學品,包含信息的數據庫,經常參與檢索化學品的機器人以及存儲環境的質量控制。 我們提供基礎設施和物流來幫助管理您的研究化合物。 它支持新藥的開發,包括藥物發現過程中的化合物儲存,製備,試驗評估和分配等物流。
根據 Pharma R&D 年度回顧,2020 年在研產品由 17,737 項組成,現在已增加到 20,109 項。 根據 FDA 的建議,生物技術和製藥公司在研發過程中嚴重依賴生物標誌物的發現和開發。
市場動態
驅動程序
技術進步
在復合管理領域引入人工智能和機器人技術等技術進步是市場增長的主要驅動力。 為了處理諸如從存儲中添加和移除化合物樣品等操作,大型製藥公司正在機器人技術的幫助下自動化化合物管理流程,並通過電子條形碼促進記錄保存。。 這些因素促進了市場的增長。
抑製劑
投資巨大
複合管理要求仍然是一項重大挑戰,但正在通過共同努力加以克服。 化合物管理設施需要大量資金用於硬件和軟件,包括建造連接到大型庫存數據庫的新的自動化液體化合物存儲系統。 因此,這些點正在抑制市場的增長。
機會
保持速度和準確性
有效的複合管理系統必須平衡速度和準確性。 大多數複合處理系統旨在減少造成大多數問題的人為乾預。 機架,傳送帶和機械臂經常用於化合物存儲和傳輸的自動化化合物備份和恢復系統。 因此,這些都是推動市場增長的因素。
威脅
低效的管理
不適當的化合物管理會在醫療保健研究領域導致各種不良後果。 化合物管理不當會導致樣品丟失或變質,不必要的支出以及其他阻礙藥物研發過程的瓶頸。 因此,這些因素阻礙了市場的擴大。
COVID-19 的影響
不同的醫療機構受到了 COVID-19 疫情的影響。 複合管理市場也產生了重大影響。 封鎖擾亂了物流和運輸。 技術進步,成本控制和改善可及性對於不久的將來的醫療改革至關重要。 前線是數字醫療和遠程醫療。 此次疫情再次印證了遠程診療和會診的重要性。 然而,隨著許多醫護人員通過電話或視頻會議工作,這一領域的增長將會增加。 對中度症狀患者的在線諮詢大大減輕了已經因患者人數不堪重負的醫院的負擔。
預計服務業在預測期內將成為最大的行業
由於藥物發現活動的增加,對化合物管理服務的需求增加以及降低與藥物發現相關的成本的需求增加,預計服務行業將實現利潤豐厚的增長。 預計大量沒有基礎設施的中小企業也將進一步刺激需求,這可能對該領域的增長產生積極影響。
預計生物樣本庫行業在預測期內的複合年增長率最高
由於參與收集和存儲生物材料的組織的增加,生物樣本庫行業預計在預測期內以最快的複合年增長率增長。 此外,對個性化醫療的日益重視增加了對生物樣本庫的需求。 此外,對用於支持研究的高質量生物樣本的需求預計會增加。 因此,上述因素預期將支持該分部的增長。
市場份額最大的地區
由於區域政府舉措,藥物發現和公私合作等持續研究,預計亞太地區在預測期內將佔據最大的市場份額。 此外,複合管理服務的低外包成本,慢性病和傳染病的流行等正在推動研究需求並促進該地區的市場增長。
複合年增長率最高的地區
由於化合物管理外包的增加,人工智能在藥物開發工作流程中的使用增加以及生物樣本庫的當前趨勢,預計北美在預測期內的複合年增長率最高。 此外,與疾病相關的發病率和死亡率上升已經確定了更多的候選藥物,促進了該地區的增長。
主要發展
2022 年 6 月,歐洲領先的技術和產品開發商 TTP 和下一代清潔能源離子交換膜和聚合物的設計者和製造商 Ionomr Innovations Inc. 設計了一種用於大規模生產的新型綠色氫。宣布他們將共同開展電解槽的示範工作。
2021 年 2 月,SPT Labtech 宣布收購機器人自動化供應商 BioMicroLab,以增強其在自動化樣本管理方面的能力。
這份報告提供了什麼
免費定制服務
訂閱此報告的客戶將免費獲得以下自定義選項之一。
According to Stratistics MRC, the Global Compound Management Market is accounted for $431.68 million in 2022 and is expected to reach $1101.66 million by 2028 growing at a CAGR of 16.8% during the forecast period. Compound management, also referred to as compound control, is defined as the management of chemical libraries, including renewal of outdated chemicals, databases containing the information, robotics often involved in fetching chemicals, and quality control of the storage environment. It provides the infrastructure and logistics that aid in managing research compounds. It aids in the development of new drugs, and entails the logistics of storing, preparing, and evaluating compounds for testing as well as dispensing them during the drug discovery process.
According to Pharma R&D annual review, the pipeline consisted of 17,737 drugs in 2020, now the number of drugs in the pipeline rose to 20,109. According to FDA recommendations, biotechnology and pharmaceutical companies depend significantly on the discovery and development of biomarkers in R&D processes.
Market Dynamics:
Driver:
Technological Advancements
Technological advancements such as introduction of artificial intelligence and robotic technology in the field of compound management is a major factor driving the market growth. Large pharmaceutical companies automate compound management process with the help of robotics technology for handling the duties of adding and removing compound samples from storage and electronic barcodes facilitate record keeping. Hence, these are the factors fueling the growth of the market.
Restraint:
Huge Investments
The requirement for compound management presents significant problems, which are being overcome by coordinated efforts. A compound management facility requires significant financial outlays for both hardware and software, including the construction of new automated liquid compound storage systems connected to a substantial inventory database. Thus, these aspects are restraining the growth of the market.
Opportunity:
Maintaining speed and accuracy
An effective compound management system must strike a balance between speed and accuracy. Most compound handling systems aim to reduce human handling because it is the source of the vast majority of problems. Racks, carousels, and robotic arms are frequently used in automated compound backup and recovery systems to store and transfer compounds. Therefore, these are the factors boosting the market growth.
Threat:
Inefficient management
Improper compound management could potentially lead to various unfavourable consequences in the healthcare research sector. Inadequate compound management leads to loss or spoilage of samples, unwanted expenditure, and various other bottlenecks that hamper the drug research and development process. Hence, these factors are hindering the expansion of the market.
COVID-19 Impact
Various healthcare facilities were affected due to the outbreak of COVID-19. There was a huge impact on Compound Management Market as well. Lockdowns disrupted logistics and transportation. An integral part of healthcare reforms in near future will be technological progress, cost containment, and increased access. The front liners are digital health and telehealth. The importance of remote diagnosis, care, and consultation is re-emphasized due to the pandemic. However, many healthcare workers are working on telephone calls and video conferencing, this segment growth will increase. Online consultation of patients with moderate symptoms has greatly reduced the burden on hospitals already swamped by counts of the patients.
The service segment is expected to be the largest during the forecast period
The service segment is estimated to have a lucrative growth, due to the rise in drug discovery activities, the growing need to manage the compound management services, and the increasing need to save costs associated with drug discovery. A significant number of small and medium-sized companies lacking infrastructure is further expected to improve the demand and thus is likely to have a positive impact on the segment growth.
The bio banking segment is expected to have the highest CAGR during the forecast period
The bio banking segment is anticipated to witness the fastest CAGR growth during the forecast period, due to the increasing number of organizations involved in the collection and storage of biomaterials. In addition, an increasing emphasis on personalized medicine is driving the need for bio banking. Besides, the need for quality bio specimens that are used to support research is expected to increase. Thus, the abovementioned factors are anticipated to support the growth of the segment.
Region with largest share:
Asia Pacific is projected to hold the largest market share during the forecast period owing to continuous research in regional government initiatives, pharmaceutical discovery, and private-public collaborations. Furthermore, the low cost of outsourcing compound management services and the high prevalence of chronic and infectious diseases in the region are driving the demand for research, thus contributing to the regional market growth.
Region with highest CAGR:
North America is projected to have the highest CAGR over the forecast period, owing to rising outsourcing of compound management, increasing use of AI in drug development workflow, and the current trend of biobanking. Furthermore, the rise in disease-related morbidity and mortality has resulted in the identification of more drug candidates, fueling growth in this region.
Key players in the market
Some of the key players profiled in the Compound Management Market include BioAscent, Brooks Life Sciences, Hamilton Company, Titian Software Limited, LiCONiC AG, Evotec, Azenta US, Inc., Tecan Trading AG, Beckman Coulter, Inc, SPT Labtech LTD., AXXAM S.p.A., Labcyte , Biosero, Wuxi Apptec, TTP Group, Frontier Scientific and Icagen, Inc.
Key Developments:
In June 2022, TTP Europe's leading technology and product development company and Ionomr Innovations Inc., designer and manufacturer of next-generation ion-exchange membranes and polymers for clean energy, announced they are joining forces to demonstrate a new green hydrogen electrolyzer designed for mass production.
In February 2021, SPT Labtech announced the acquisition of BioMicroLab, a robotics automation provider, to strengthen its capabilities in automatic sample management.
Types Covered:
Sample Types Covered:
Applications Covered:
End Users Covered:
Regions Covered:
What our report offers:
Free Customization Offerings:
All the customers of this report will be entitled to receive one of the following free customization options: